Bank of America – Merrill Lynch upgraded its rating on shares of Celgene Corp. (CELG: Quote) Tuesday to “Buy” from “Neutral.”
Celgene has risen above Tuesday’s range in the last 15 minutes and is currently higher by 1.04 at $98.71. The stock has climbed to its seventh consecutive new high for the year.
Click here to receive FREE breaking news email alerts for Celgene Corporation and others in your portfolio
by RTT Staff Writer
For comments and feedback: editorial@rttnews.comBusiness News